|

BMS-986463 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Bristol-Myers Squibb1

Indications

  • Uterine Serous Carcinoma (USC)1
  • High-grade Serous Ovarian Carcinoma (HGSOC)1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Lung Cancer1
  • Cancer1

Los Angeles, California1 trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

USC/Norris Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.